There is a moment in almost every consultation I have had with a professional in their late thirties or forties when the conversation reaches an impasse neither of us expected.
They have come with a concern that is real but difficult to articulate – a change in how they feel, a shift in capacity they can sense but not measure, a suspicion that something is different from three or five years ago. They have done the responsible thing: consulted their GP, had blood drawn, perhaps seen a specialist. And they have been told, with genuine clinical accuracy, that everything looks normal. The impasse is not that the doctor was wrong. The impasse is that both parties were correct – the physician in their assessment, the patient in their experience – and the system has no language for that situation.
I have spent – and do spend – most of my clinical career inside that system. As a consultant anaesthetist, I work at the sharp end of hospital medicine – the part where defined pathology meets decisive intervention. A patient arrives with a measurable problem – we measure it, treat it, stabilise it. The architecture is extraordinary, and I have deep respect for what it achieves. But the architecture has a structural property that most patients never see clearly: it is built around thresholds. A blood pressure becomes hypertension at a specific number. A fasting glucose becomes diabetes at a specific number. A haemoglobin becomes anaemia at a specific number. Short of those thresholds, the system has little to offer – not because it doesn’t care, but because it was not designed to operate in the space between “diagnosable” and “optimal.”
This is the space where most of the adults I speak to in my clinical work actually live. They are not ill. They would not meet criteria for any defined condition. Their laboratory results fall within reference ranges – ranges that were established, it is worth understanding, by measuring large populations that include people with early pathological changes, suboptimal lifestyles, and undiagnosed subclinical dysfunction. “Normal” on a blood test means you fall within the distribution – it does not mean the distribution represents where you personally function best. A fasting insulin of 10 mU/L is within range. It is also, in my clinical judgement, a number that tells me something important about metabolic trajectory – something that will not trigger a referral, will not generate a diagnosis, and will not appear on any alert in any electronic health record. The system is not failing – it is functioning precisely as it was designed to function. The question is whether what it was designed to detect is the same thing the patient is asking about.
What strikes me most is how differently the same information reads depending on which lens you apply.
In hospital medicine, a physician sees a patient at a point in time. The question is immediate: what is wrong now, and what do we do about it? But a physician who follows a patient across time is asking a different question: given where these markers are now, where does the trajectory point in ten or twenty years?
These are not competing approaches – they are different tools for different problems. But the second question is almost never asked inside the conventional system, because the conventional system is not structured to ask it. A GP appointment is fifteen minutes. A specialist referral requires a defined indication. The entire pathway is optimised for identifying and managing disease, not for interpreting the slow, multi-system, subclinical drift that constitutes ageing in an otherwise functional adult.
Consider cardiovascular disease. Autopsy studies – some dating back to examinations of young soldiers killed in conflict – have consistently demonstrated that atherosclerotic changes begin in adolescence and early adulthood. Fatty streaks in coronary arteries have been found in individuals in their twenties who were, by every clinical measure available during their lifetime, healthy. The disease exists decades before it declares itself. When a patient in their forties is told they have “no heart disease,” the precise clinical meaning is “no heart disease detectable by the investigations performed at this time”. That is a true and important statement. But it is not the same statement as “your cardiovascular system is healthy,” and the gap between those two statements is where a great deal of unspoken anxiety lives.
The same temporal mismatch applies to neurodegeneration. Alzheimer’s disease is not, as it is commonly understood, a disease of old age. It is a disease whose pathological signature – amyloid accumulation, tau-mediated neuronal injury – begins in midlife and progresses silently for years or decades before cognitive symptoms appear. By the time the diagnosis is made, the biological process has been running for longer than most patients would find comfortable to contemplate. The medical system is designed to act when evidence is actionable. The patient’s experience of change begins long before that threshold is reached.
This is the distinction I find myself returning to repeatedly: human perception operates on gradients, while medicine operates on thresholds.
You feel the gradient – the slow erosion of morning sharpness, the recovery that takes a day longer than it used to, the subtle shift in body composition that no single measurement captures. Medicine acts at the threshold – the number that crosses a line, the symptom that meets criteria, the scan that shows a lesion. Between the gradient and the threshold lies a territory that is genuinely difficult to navigate. It is not illness, and it is not health as you remember it. It is the space where most high-functioning adults over forty actually exist, and it is the space that conventional medicine is least equipped to address – not through any fault of the clinicians working within it, but because the architecture was built for a different purpose.
What I have come to believe, after years of working on both sides of this divide, is that the most useful thing a physician can offer in this territory is not treatment – it is interpretation. Not a diagnosis, but a framework. Not a protocol, but a way of understanding which changes are expected, which are concerning, which warrant investigation, and which are noise. The aim is not to medicalise the experience of ageing – that would be its own kind of harm. The aim is to make the experience navigable: to help someone approach their own physician with better questions, clearer priorities, and appropriate timing. Because health decisions in this territory are rarely binary. They are almost always about thresholds. And understanding where you stand relative to those thresholds, and in which direction you are moving, is often more valuable than any single number on a blood test.
The phrase “everything looks normal” is not a dismissal. It is an accurate clinical statement with a specific and limited meaning. Understanding its limits – what it includes and what it cannot include – is, in my experience, the first step toward using medical care more effectively. And sometimes, the most important thing a physician can do is not to provide an answer, but to help reframe the question.